MedPath

Injectable platelet rich fibrin in androgenetic alopecia ( Patterened baldness)

Phase 3
Conditions
Health Condition 1: L649- Androgenic alopecia, unspecified
Registration Number
CTRI/2023/08/056292
Lead Sponsor
Dr Sahana N C
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients willing to give informed consent

2. Patients of either gender aged 18 to 60 years.

3. Androgenetic Alopecia in males with Norwood-Hamilton grade 2-6 and females beyond grade 1 according to Ludwigâ??s scale.

4. Patients willing for follow up.

Exclusion Criteria

1. patients with Alopecia other than Androgenetic Alopecia

2. Patients with active infection at the local site

3. Patients with keloidal tendency

4. Patients with blood coagulopathies and platelets count below 1,50,000cell/mm3

5. Pregnant and lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Trichoscopic improvement/ maintenance in the hair density / diameterTimepoint: 4 sessions at 2 weekly intervals <br/ ><br>Final assessment at the end of 3 months
Secondary Outcome Measures
NameTimeMethod
Improvements in visual analogue scale <br/ ><br>Improvements in global photographyTimepoint: At the end of 3 months
© Copyright 2025. All Rights Reserved by MedPath